Encore: Research Update From Summit Therapeutics on Ridinilazole
C. diff. Spores and More
Join Us With Guest Dr. Richard Vickers, Ph.D., Chief Scientific Officer at Summit Therapeutics joining us to discuss their research on a new antibiotic to treat a C. difficile infection. Listen Now